The global medical dry fluorescence immunoassay analyzer market is expected to grow at a CAGR of 14.5% over the forecast period from 2020 to 2028. Rising demand across the world from the health care centers such as laboratories Clinics and other healthcare is considered as one of the major factors driving the growth of the market. Moreover, the penetration of the technologically advanced products like compact size analyzers, is also considered another secondary factor for growth. In addition, rising percentage of the chronic disorders, which require early treatment followed with diagnosis is also assisting in propel the growth of the market. However, despite the technological adoption the high cost of the device is the major factor which restrain the product growth in the medical device market. Nonetheless, ongoing research and technological advanced will bring the huge growth opportunities within the forecasted year.
Dry fluorescence immunoassay analyzer is a test strip reader based on the photoelectric detection principle. For the final assessment, the analyzer uses immunoassay fluorescence products. The analyzer measures, and automatically reports a quantitative test result through systematic calculation and processing. The product is also available in portable form, which is easy-to-use and designed to provide accurate results. It is also considered as an ideal tool to assist medical personnel to diagnose COVID-19 cases more accurately. Government and non-government investment in the area of diagnostic research increasing the demand of these devices.
The global medical dry fluorescence immunoassay analyzer market is categorized based on product, and application. Region wise, North America hold the largest market in year 2020; however, increasing investment followed by rising per-capita healthcare expenditure make Asia Pacific to be the fastest growing region by 2028, with a CAGR of over 17.5%.
Key players serving the global medical dry fluorescence immunoassay analyzer market include AESKU.SYSTEMS GmbH and Co. KG, Alere San Diego, Inc., Astute Medical, Inc., Boditech Med Inc., NanoEnTek Inc., Phadia AB, Quidel Corporation, Radiometer Medical ApS, Thermo Fisher Scientific Inc., Wako Pure Chemical Industries, Ltd, Wallac Oy, Lansionbio, Labism, ReLIA Biotech among other prominent players.
Key segments of the global Medical Dry Fluorescence Immunoassay Analyzer market
Product Overview, 2018-2028 (USD Billion)
- Single Channel
Application Overview, 2018-2028 (USD Billion)
Regional Overview, 2018-2028 (USD Billion)
- North America
- United Kingdom
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa
- South Africa
- Rest of Middle East and Africa
Reasons for the study
- The purpose of the study is to give an exhaustive outlook of the global medical dry fluorescence immunoassay analyzer industry
- The overall segmentation of medical dry fluorescence immunoassay analyzer market, especially key segments are thoroughly studied.
- Presence of major players and their wide product portfolio across developed countries is anticipated to further boost the growth of medical dry fluorescence immunoassay analyzer market
What does the report include?
- The study on the global medical dry fluorescence immunoassay analyzer market includes analysis of qualitative market indicators such as drivers, restraints, challenges and opportunities
- Additionally, the market competition has been evaluated using the Porter’s five forces analysis
- The study covers qualitative and quantitative analysis of the market segmented on the basis of applications, and products. Moreover, the study provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the considered segments
- The study includes the profiles of key players in the market with a significant global and/or regional presence
Who should buy this report?
- The report on the global medical dry fluorescence immunoassay analyzer market is suitable for all the players across the value chain including raw material suppliers, medical dry fluorescence immunoassay analyzer providers, pharmaceutical manufacturers, distributors, suppliers and retailers
- Venture capitalists and investors looking for more information on the future outlook of the global medical dry fluorescence immunoassay analyzer market
Consultants, analysts, researchers, and academicians looking for insights shaping the global medical dry fluorescence immunoassay analyzer market
Medical dry fluorescence immunoassay analyzers find a huge scope within the forecasted year. The product is mainly used by medical professionals for the outpatient's department, clinic, research centers, and other healthcare centers. Recently, the corona virus outbreak across the world along with a rising percentage of chronic diseases is major factor that allows the firm to increases the production of such devices. The increasing awareness about the novel technologies in the healthcare sector assists in the increasing adoption rate for the products and thus expected to create a huge potential for the dry fluorescence immunoassay analyzers market.
The global medical dry fluorescence immunoassay analyzer market has been segmented based on product and application. The global medical dry fluorescence immunoassay analyzer industry is segmented the product type into the multi and single-channel type. Multi-channel type accounts for the largest market share in the year 2020. In addition, researchers have projected that demand for the same will remain strong during the forecast period. It is estimated that the multi-channel segment accounted for approximately 62.5% of revenue in the year 2020. The growth is mainly associated due to its wide application compared to the single-channel type. The multi-channel dry fluorescence immunoassay analyzer is a device which can perform both quantitative and qualitative analysis on various type of infection, chronic diseases and various type of respiratory disorders.
The single-channel dry fluorescent immuno-analyzer is quite different from the multi-channel type. The single-channel offers complete testing in the operation of one step. The product use blood, urine, plasma, serum as a test sample for the diagnosis. At present, it is used by various medical institutions, pet hospitals, quarantine monitoring centers, environmental monitoring centers, and others. On the contrary, the multi-channel products multiple incubation chambers which make products more accurate and increasing sensitivity toward the result. Both the systems are enabled with android operating system for the better visualization of the data.
In terms of application, the dry fluorescent immuno-analyzer market is classified into clinics, research laboratories and others. Clinics acquired the largest market share in the year 2020. The number of people visiting the diagnostic centers are comparatively much higher than other. The various medical institution such as clinical department, emergency laboratory department, community medical centers, primary healthcare centers are among the major end-users of the dry fluorescent immuno-analyzer market. Due to the recent pandemic of COVID 19, the market is seen as a boost in the clinical diagnostic segment for the diagnosis of suspected patients. The medical manufacturer also keen to design technologically advanced products for their customer.
In regions type, the report classified the medical dry fluorescence immunoassay analyzer market into America, Europe, Asia Pacific, and Middle East & Africa. North America holds the largest shares both in the terms of consumption and revenue generation. As per CDC, in 2016 about 150 million Americans people were expected to be suffering from one or more chronic diseases and the same surge is seen in the Covid 19 pandemic cases. In North America, it is estimated that more than 82% of the United States population living in the urban Area followed by the European Union which is 73%, a driving factor for the market. The rapid adoption of new technology and high penetration rate of the products in the region is considered as one the major factor which promotes the growth of the market. Rising per-capita healthcare expenditure in the Asia Pacific counties like China, Japan, India also the associated factors for the market growth.
In Latin America, Brazil holds the largest market share due to its population density and the rising investment in the healthcare sector. Brazil is also one of the most affected countries by COVID 19 in the Latin American region